Incyte (INCY) Inventory (2012 - 2026)
Incyte (INCY) reported Inventory of $115.6 million for Q1 2026, up 80.73% on a YoY basis from $64.0 million in Q1 2025, and up 14.41% quarter-over-quarter from $101.1 million in Q4 2025.
Incyte (INCY) Inventory (2012 - 2026) Analysis & Trends
Incyte has reported Inventory for 15 years, with the latest figure at $115.6 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory rose 80.73% year-over-year to $115.6 million; the trailing twelve-month figure through Mar 2026 stood at $115.6 million (up 80.73% YoY), and the FY2025 full-year result was $101.1 million, up 71.66% from the prior year.
- Inventory for Q1 2026 stood at $115.6 million, up from $101.1 million in the prior quarter.
- The five-year high for Inventory was $115.6 million in Q1 2026, with the low at $35.5 million in Q1 2022.
- Historically, Inventory has averaged $65.6 million across 5 years, with a median of $63.0 million in 2023.
- Annual changes were most pronounced in 2022 — Inventory soared 226.84% — and 2023, when it plunged 34.13%.
- Incyte's Inventory stood at $42.0 million in 2022, then soared by 49.95% to $63.0 million in 2023, then decreased by 6.51% to $58.9 million in 2024, then surged by 71.66% to $101.1 million in 2025, then advanced by 14.41% to $115.6 million in 2026.
- The last three Inventory figures came in at $115.6 million (Q1 2026), $101.1 million (Q4 2025), and $83.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 115.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 115.62 Mn |
| Dec 31, 2025 | 101.06 Mn |
| Sep 30, 2025 | 83.40 Mn |
| Jun 30, 2025 | 83.42 Mn |
| Mar 31, 2025 | 63.98 Mn |
| Dec 31, 2024 | 58.87 Mn |
| Sep 30, 2024 | 70.44 Mn |
| Jun 30, 2024 | 100.70 Mn |
| Mar 31, 2024 | 63.60 Mn |
| Dec 31, 2023 | 62.97 Mn |
| Sep 30, 2023 | 57.20 Mn |
| Jun 30, 2023 | 35.90 Mn |
| Mar 31, 2023 | 40.88 Mn |
| Dec 31, 2022 | 42.00 Mn |
| Sep 30, 2022 | 45.87 Mn |
| Jun 30, 2022 | 54.50 Mn |
| Mar 31, 2022 | 35.50 Mn |
| Dec 31, 2021 | 27.90 Mn |
| Sep 30, 2021 | 21.30 Mn |
| Jun 30, 2021 | 16.68 Mn |